$13.51
1.078.6%
Last update: Nov 9, 4:00 PM
Eloxx Pharmaceuticals Inc
ELOXNASDAQ
The average analyst price target for Eloxx Pharma is $37.50, 190.2% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $32 to $40. The latest change came on Oct 28, 2026, when Guggenheim lowered its price target on Eloxx Pharma from $43 to $40 and kept a Buy rating.
Price Target Range — 2 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
